A systematic study of Epstein-Barr virus serologic assays following acute infection

American Journal of Clinical Pathology

Volumn 117, Issue 1, 2002, Pages 156-161

  Rea, Thomas D ^a   Ashley, Rhoda L ^a   Russo, Joan E ^a   Buchwald, Dedra S ^a  

^a Pioneer Square Clinic ^*  (United States)

Author keywords

Acute infectious mononucleosis; Enzyme linked immunosorbent assay; Epstein Barr virus; Immunofluorescence; Serology; Virology

Indexed keywords

CELL NUCLEUS ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; VIRUS CAPSID ANTIGEN;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; ASSAY; BACTERIAL INFECTION; CLINICAL TRIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; HUMAN; IMMUNOFLUORESCENCE; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MONONUCLEOSIS; PRIORITY JOURNAL; SEROLOGY;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CAPSID; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 0036141375     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/ETK2-L9MG-L6RA-N79Y     Document Type: Article

References (30)

1. Epstein-Barr virus (infectious mononucleosis)
2. Complications of infectious mononucleosis
3. Effect of acyclovir on infectious mononucleosis: A double-blind placebo-controlled study
4. Acyclovir treatment in infectious mononucleosis: A clinical and virological study
5. A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: Specificity and sensitivity of the tests and persistence of antibody
6. Humoral immune response in infectious mononucleosis: Late emergence of anti-EA-R and the effects of corticosteroid therapy
7. Evaluations of enzyme-linked immunosorbent assay procedure for determining specific Epstein-Barr virus serology and of rapid test kits for diagnosis of infectious mononucleosis
8. The significance of serum IgM, IgA, and IgG antibodies specific for Epstein-Barr virus as determined by immunoperoxidase assay in the rapid diagnosis of infectious mononucleosis
9. Enzyme-linked immunosorbent assay of antibodies to Epstein-Barr virus nuclear and early antigens in patients with infectious mononucleosis and nasopharyngeal carcinoma
10. Antibody responses to Epstein-Barr virus-determined nuclear antigen EBNA-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection
11. Epstein-Barr virus specific diagnostic tests in infectious mononucleosis
12. Antibodies to Epstein-Barr virus-associated nuclear antigen in Infectious mononucleosis
13. Long-tern serological follow-up of patients for Epstein-Barr virus after recovery from infectious mononucleosis
14. Study of Epstein-Barr virus (EBV) antibodies: IgG and IgM anti-VCA, IgG anti,EA and Ig anti-EBNA obtained with an original microtiter technique: Serological criterions of primary and recurrent EBV infections and follow-up of infectious mononucleosis seroepidemiology of EBV in Belgium based on 5178 sera from patients
15. Differences in EBV-specific antibody patterns at onset of infectious mononucleosis
16. Cellular immunity in infectious mononucleosis: Specific reactivity to Epstein-Barr virus antigens and correlation with clinical and hematologic parameters
17. EBNA antibodies are more useful than complement fixing antibodies in monitoring infectious mononucleosis patients
18. Immunoglobulins and EB virus antibodies in infectious mononucleosis
19. Acyclovir and prednisolone treatment of acute infectious mononucleosis: A multicenter, double-blind, placebo-controlled study
20. Lack of effect of peroral acyclovir for the treatment of acute infectious mononucleosis
21. Antibodies to Epstein-Barr virus-induced early antigens in blood donors
22. The relationship between the chi-square statistics from matched and unmatched analyses
23. Clinical reliability of IgG, IgA, and IgM antibodies in detecting Epstein-Barr virus at differing stages of infection with a commercial nonrecombinant polyantigenic ELISA
24. Detection of Epstein-Barr virus-specific antibodies by an automated enzyme immunoassay: Performance evaluation and cost analysis
25. Development and evaluation of an Epstein-Barr virus immunoglobulin M enzyme-linked immunosorbent assay based on the 18-kilodalton matrix protein for diagnosis of primary EBV infection
26. Serological diagnosis of infectious mononucleosis using three anti-Epstein-Barr virus recombinant ELISAs
27. Evaluation of three commercial enzyme-linked immunosorbent assays and two latex agglutination assays for the diagnosis of primary Epstein-Barr virus infection
28. Rapid diagnosis of acute Epstein-Barr virus infection by an indirect enzyme-linked immunosorbent assay for specific immunoglobulin M (IgM) antibody without rheumatoid factor and specific IgG interference
29. Evaluation of five enzyme immunoassays for detection of immunoglobulin antibodies to Epstein-Barr virus viral capsid antigens